In a report released yesterday, Lili (Aurélie) Nsongo from Leerink Partners maintained a Hold rating on Arcturus Therapeutics ( ARCT – Research Report ), with a price target of $63.00. Discover ...

Arcturus Therapeutics Holdings Inc is a biotechnology firm based in San Diego, California, specializing in the development of innovative mRNA medicines and vaccines. With a focus on addressing ...

The Japanese drugs giant Takeda and the US biotech Arcturus Therapeutics have joined the hunt for therapies for the COVID-19 coronavirus. As the infection and death count continues to rise across ...

Several pharma companies – Arcturus Therapeutics, Bayer, GSK, Moderna, Pfizer, and Sanofi - are all racing to develop mRNA influenza vaccines. GSK has teamed up with CureVac and currently has ...

1 Day ARCT 2.23% DJIA -1.33% Russell 2K 0.92% Health Care/Life Sciences -0.86% ...

1 Day ARCT -2.55% DJIA -1.73% Russell 2K -1.03% Health Care/Life Sciences 0.16% ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

March S&P 500 E-Mini futures (ESH25) are down -0.92%, and March Nasdaq 100 E-Mini futures (NQH25) are down -1.14% this morning as higher Treasury yields, trade war worries, and disappointing tech ...

This company does not have a dividend history.

ARCT Arcturus Therapeutics Holdings Inc.